Registering Genomics and Imaging of Tumors (ReGIT)
This study is investigating how brain tumors might mutate over time, and whether new brain imaging tools like MRI and PET can predict these mutations.
• Subject is between 18 and 89 years of age.
• Subject has radiologically-diagnosed or suspected WHO Grade II-IV glioma based on physician review or conformance with published WHO criteria as evaluated by the PI\*.
• Subject is treatment-naïve with the exception of previous biopsy for the above condition.
• Subject is planning to undergo surgical resection and biopsy of their brain tumor.
• Subject has sufficient tissue so that the study team is able to acquire at least 2 biopsy samples during resection.
• Subject is able to read and write in English.
• Subject is able to lay supine for up to 80 minutes.
• Subject is able to hold still during MRI procedures.
• Subject or their LAR has signed the consent form for participation in the study.